Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-05-15
1989-01-03
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548575, A61K 3140, C07D29508
Patent
active
047957581
ABSTRACT:
The present invention relates to novel products of the formula: ##STR1## in which R is selected from the group comprising H, OH, --O--COCH.sub.3 and --O--CO--(CH.sub.2).sub.n --CH.sub.3, in which n is between 1 and 8, and the salts of the products of the formula (I) with pharmaceutically acceptable acids.
REFERENCES:
patent: 2914552 (1959-11-01), Hiltmann et al.
patent: 3205136 (1965-09-01), Tedeschi
patent: 3740397 (1973-06-01), Lafon
patent: 3767819 (1973-10-01), Leeming et al.
patent: 3793366 (1974-02-01), Krapcho
Wheatley, et al., J. Org. Chem., 23, 568-571.
Goodman et al., "The Pharmacological Basis of Therapeutics", pp. 549-565, Chapter 26 (1970), 4th Ed., The Macmillan Co., London.
Danree Bernard
Houziaux Patrick
Lacolle Jean-Yves
Brust Joseph Paul
Societe a Responsabilite Limitee: Institut de Recherches Chimiqu
LandOfFree
5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2168689